Improved Gastrointestinal Symptoms and Quality of Life after Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Receiving Tacrolimus

It is reported that a conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) relieves gastrointestinal (GI) symptom burden and improves health-related quality of life (HRQoL). However, it is unclear whether renal transplant recipients using tacrolimus receive the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hwang, Hyeon Seok, Hyoung, Bok Jin, Kim, Sol, Oh, Ha Young, Kim, Yon Su, Kim, Jung Kyung, Kim, Yeong Hoon, Kim, Yong Lim, Kim, Chan Duck, Shin, Gyu Tae, Yang, Chul Woo
Format: Artigo
Idioma:Inglês
Publicat: The Korean Academy of Medical Sciences 2010
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2995230/
https://ncbi.nlm.nih.gov/pubmed/21165291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2010.25.12.1759
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars